Equities

Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,258.95
  • Today's Change-4.05 / -0.32%
  • Shares traded261.22k
  • 1 Year change-0.29%
  • Beta0.8026
Data delayed at least 15 minutes, as of Nov 21 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Narayana Hrudayalaya Limited is engaged in the business of rendering medical and healthcare services. The Company has a network of multispecialty and super-specialty hospitals spread across multiple locations. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental / behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, oral oncology and maxillofacial surgery, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of about 18 hospitals and three heart centers across India along with an overseas presence in the Cayman Islands.

  • Revenue in INR (TTM)52.21bn
  • Net income in INR7.79bn
  • Incorporated2000
  • Employees11.66k
  • Location
    Narayana Hrudayalaya Ltd2nd Floor, No. 261/ABommasandra Industrial Area, Hosur RoadAnekal ThalukBANGALORE 560099IndiaIND
  • Phone+91 8 071222222
  • Fax+91 8 071222611
  • Websitehttps://www.narayanahealth.org/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Yatharth Hospital & Trauma Cre Srvcs Ltd7.74bn1.29bn52.02bn2.19k39.255.5830.236.7215.4415.4492.57108.590.795215.713.583,542,136.0013.2711.2714.1013.7379.4477.7616.6812.307.2086.400.08820.0028.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd20.39bn570.45m65.16bn6.15k115.377.5626.263.204.054.05145.2461.830.743520.915.923,316,034.002.23-2.263.09-3.0553.2253.783.00-3.500.84191.370.6324--12.8014.3564.08---0.3308--
Jupiter Life Line Hospitals Ltd11.73bn1.85bn97.71bn2.77k53.547.7642.218.3327.8327.83176.26191.930.89519.4420.094,238,544.0014.12--15.75--82.00--15.78--3.1552.160.00--19.83--142.25------
Metropolis Healthcare Ltd12.85bn1.48bn103.60bn4.31k70.238.7541.058.0628.7728.77249.83231.050.81856.7210.002,979,279.009.4713.6511.2316.9478.9175.4311.5614.661.4910.320.137623.525.189.67-10.541.2521.84--
Vijaya Diagnostic Centre Ltd6.27bn1.33bn109.69bn2.05k82.7815.1355.5017.4912.9112.9161.0770.640.611414.8354.303,054,368.0013.0014.1014.4015.5487.7985.5821.2621.202.307.540.2866.6619.2913.3640.4020.977.58--
Sagility India Ltd48.61bn2.08bn136.93bn35.86k65.811.8016.282.820.44450.444510.3816.250.4618--4.871,387,054.001.98--2.21--99.00--4.28----2.790.166--12.69--58.99------
Rainbow Children's Medicare Ltd14.25bn2.32bn160.30bn3.94k69.3911.9344.3611.2522.7522.75139.95132.290.68517.9117.843,616,084.0011.179.8912.0410.9687.4582.9616.3113.804.125.020.3602--10.5119.032.9337.2332.22--
Aster DM Healthcare Ltd16.42bn2.51bn215.67bn14.02k89.026.2855.3713.134.86108.0832.2168.980.14671.201.261,171,811.002.852.244.163.6040.8259.7319.404.261.827.410.3501--23.54-14.2212.28-18.156.87--
Krishna Institute Of Medical Sciencs Ltd27.05bn3.31bn226.96bn5.01k68.5311.3443.188.398.288.2867.5950.030.676510.768.265,396,635.009.1013.7111.3316.7379.3754.2913.4515.530.86788.110.43840.0013.6722.17-7.78--52.94--
Dr. Lal PathLabs Ltd23.46bn4.01bn253.36bn4.10k63.1512.6646.1310.8048.1748.17281.60240.300.930610.5526.725,724,423.0016.1315.4920.1219.3880.2876.1317.3315.992.7720.160.088923.8610.4013.1049.7812.436.4431.95
Narayana Hrudayalaya Ltd52.21bn7.79bn256.31bn11.66k32.918.0524.794.9138.3538.35257.10156.860.946620.969.504,477,685.0014.1310.7918.0813.9760.9247.1114.929.721.467.620.34689.6410.9111.8930.1967.8945.2731.95
Data as of Nov 21 2024. Currency figures normalised to Narayana Hrudayalaya Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

9.74%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Oct 20243.38m1.65%
Axis Asset Management Co. Ltd.as of 30 Sep 20242.89m1.41%
The Vanguard Group, Inc.as of 06 Nov 20242.75m1.34%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Aug 20242.22m1.09%
DSP Asset Managers Pvt. Ltd.as of 31 Oct 20242.17m1.06%
Templeton Asset Management Ltd.as of 30 Sep 20241.96m0.96%
ICICI Prudential Life Insurance Co. Ltd. (Invt Port)as of 31 Oct 20241.59m0.78%
BlackRock Fund Advisorsas of 07 Nov 20241.06m0.52%
Dimensional Fund Advisors LPas of 07 Nov 20241.02m0.50%
Norges Bank Investment Managementas of 30 Jun 2024863.85k0.42%
More ▼
Data from 30 Jun 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.